CL — Colgate-Palmolive Company
Is CL overbought or oversold? Here is the current MarketMoodz read.
Colgate-Palmolive Company (CL) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Consumer Defensive name (Household & Personal Products) last closed at $99.61. The rating moved from Overbought to Neutral on November 17, 2026.
- Public ratingNeutral (as of November 17, 2026)
- Last close$99.61
- Last changeMoved from Overbought to Neutral on November 17, 2026
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
AI analysis
Colgate-Palmolive Company (CL) combines durable brand franchises in oral care and household products with steady cash generation and conservative capital allocation. Near-term market dynamics—marked by a defensive rotation into staples—provide support for stable demand and downside protection. Growth is likely to remain modest and driven by pricing, mix, and selective innovation, while margins could face pressure from input costs and currency swings. Balance-sheet strength and shareholder-return policies underpin resilience, but execution and competitive intensity are the main variables for upside momentum over the coming month.
Key factors
- Colgate-Palmolive Company (CL) is a leading global oral care and household consumer staples franchise with strong brand equity and pricing power in core categories.
- Defensive sector flows into consumer staples support near-term demand and reduce downside volatility relative to cyclicals.
- Consistent free cash flow generation and a history of stable margins enable continued dividend support and share-repurchase flexibility.
- Global distribution scale and strong retail shelf placement provide resilience versus smaller competitors and private-label incursions.
- Ongoing product innovation and marketing investments can sustain modest organic growth and mix benefits in emerging markets.
- Relative valuation appears reasonable versus large-cap staples, offering upside in a low-volatility environment.
Risks
- Slower-than-expected organic growth in mature markets as oral-care penetration saturates and unit volumes remain flat.
- Input-cost inflation (raw materials, packaging, freight) or adverse FX movements could compress margins if not fully passed through.
- Intensifying competition from private-label and regional players leading to market-share erosion or increased promotional pressure.
- Execution risk around innovation, marketing spend effectiveness, or supply-chain disruptions that raise working capital needs.
- Macroeconomic weakness that reduces consumer purchasing frequency for premium products, particularly in discretionary channels.
- Regulatory or litigation risks related to product safety, labeling, or environmental compliance in key markets.
Latest MarketMoodz coverage
See today's live rating, score and targets
Members see the live hourly rating for CL — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.